Grieg Seafood (0GW8)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 22.87 |
|---|---|
| 52-week range | 22.60 – 78.25 |
| Return, 1 month / 3 months | −11.4% / −24.4% |
| Return, 1 year / 3 years | −66.6% / −64.9% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 71.8% |
| Worst drawdown (1 year) | -69.8% |
| Average daily value traded | 0.19M NOK |
| Dividend yield | 8.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grieg Seafood is a salmon farming company based in Norway. It raises Atlantic salmon at sea sites in Norway and Canada, then processes and sells the fish to seafood buyers and markets around the world. Its business covers the farming, harvesting and sale of salmon, and it supplies customers in the global seafood trade. The company is part of the Grieg group and focuses on producing salmon for food markets.
Grieg Seafood trades under the code 0GW8 on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grieg Seafood (0GW8) trades on the London Exchange in UK. It last closed at NOK 22.87 on 23 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 3,545 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 66.6% and over the last three months it fell 24.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -47.1% | ||
| From 52-week high | -70.4% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.4% | ||
| 6-month return | -33.1% | ||
| 12-month return, skipping the last month | -62.4% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 71.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -69.8% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.19M NOK | ||
| Zero-volume days | 8.3% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.9% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −11.4% |
| 3 months | −24.4% |
| 6 months | −33.1% |
| 1 year | −66.6% |
| 3 years | −64.9% |
| 5 years | −71.8% |
Signals
| 50-day / 200-day average | 26.14 / 43.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | NOK 2.0467 |
| 20 Jun 2024 | NOK 1.7500 |
| 28 Jun 2023 | NOK 4.5000 |
| 10 Jun 2022 | NOK 3.0000 |
| 25 Nov 2019 | NOK 2.0000 |
| 14 Jun 2019 | NOK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.